Profile data is unavailable for this security.
About the company
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. is a China-based company principally engaged in the research and development, production and sales of pharmaceutical products. The Company's main products are antibiotics, circulatory system drugs and biological products, including garlic oil soft capsules, lecithin soft capsules and deep-sea fish oil soft capsules. Its bulk pharmaceutical chemicals (BPCs) include macrolide antibiotics, antiviral, anti-tumor, cardiovascular, hormones and weight loss drugs. The Company also offers topical preparations, such as gynecological suppositories and dermatology preparations.
- Revenue in CNY (TTM)11.78bn
- Net income in CNY843.91m
- Incorporated1996
- Employees11.61k
- LocationShanghai Shyndec Pharmaceutical Co LtdNo. 378 Jianlu Road, Pudong New AreaSHANGHAI 200137ChinaCHN
- Phone+86 2 152372865
- Fax+86 2 158480136
- Websitehttp://www.shyndec.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sunshine Guojian Pharmcutcl Shngh Co Ltd | 1.07bn | 352.22m | 13.92bn | 965.00 | 39.52 | 2.79 | -- | 12.97 | 0.571 | 0.571 | 1.74 | 8.09 | 0.2078 | 1.14 | 9.25 | 1,112,527.00 | 6.61 | 1.32 | 6.93 | 1.41 | 77.85 | 80.74 | 31.81 | 6.55 | 6.66 | -- | 0.01 | 8.25 | 22.84 | -2.35 | 497.63 | -4.44 | 21.22 | -- |
| Suzhou Zelgen Biopharmaceuticals Co Ltd | 386.57m | -260.85m | 14.00bn | 867.00 | -- | 8.78 | -- | 36.22 | -1.00 | -1.00 | 1.49 | 6.02 | 0.1621 | 0.2594 | 3.75 | 445,874.00 | -11.74 | -27.13 | -20.82 | -39.20 | 92.29 | 92.75 | -72.40 | -220.71 | 2.15 | -- | 0.3842 | -- | 27.83 | 211.81 | 39.08 | -- | 41.38 | -- |
| Henan Lingrui Pharmaceutical Co., Ltd. | 3.43bn | 614.24m | 14.06bn | 2.53k | 22.74 | 4.76 | -- | 4.10 | 1.09 | 1.09 | 6.09 | 5.21 | 0.7246 | 2.04 | 13.84 | 1,356,471.00 | 12.97 | 10.68 | 21.27 | 16.56 | 71.74 | 74.42 | 17.90 | 14.92 | 1.26 | -- | 0.0122 | 72.80 | 10.31 | 10.03 | 22.09 | 18.49 | -16.47 | 39.77 |
| Changchun BCHT Biotechnology Co | 1.92bn | 543.19m | 14.77bn | 1.24k | 27.13 | 3.61 | -- | 7.71 | 1.32 | 1.32 | 4.64 | 9.88 | 0.4116 | 0.8459 | 1.55 | 1,543,550.00 | 11.67 | 9.95 | 14.14 | 12.81 | 89.90 | 86.63 | 28.36 | 24.03 | 2.03 | -- | 0.0158 | 10.55 | 70.30 | 12.36 | 175.98 | 31.37 | 21.04 | -- |
| BrightGene Bio-Medical Technology Co Ltd | 1.21bn | 195.77m | 15.10bn | 1.16k | 78.22 | 6.22 | -- | 12.43 | 0.4569 | 0.4569 | 2.87 | 5.75 | 0.2463 | 1.69 | 4.43 | 1,051,700.00 | 3.43 | 6.53 | 4.29 | 7.93 | 54.92 | 56.93 | 13.93 | 19.90 | 1.45 | 4.86 | 0.4787 | 29.31 | 15.94 | 23.68 | -15.51 | 22.56 | 29.13 | -- |
| Shanghai Shyndec Pharmaceutical Co Ltd | 11.78bn | 843.91m | 15.18bn | 11.61k | 17.70 | 1.19 | -- | 1.29 | 0.6394 | 0.6394 | 8.95 | 9.48 | 0.6069 | 3.08 | 6.61 | 1,014,487.00 | 5.75 | 4.85 | 8.50 | 8.17 | 37.09 | 43.00 | 9.48 | 7.03 | 1.82 | -- | 0.1057 | 17.52 | -6.86 | 1.29 | 10.21 | -0.3897 | -2.21 | 0.00 |
| Liaoning Cheng Da Co Ltd | 11.18bn | 17.48m | 15.31bn | 3.36k | 770.00 | 0.525 | -- | 1.37 | 0.013 | 0.013 | 7.34 | 19.07 | 0.2358 | 4.41 | 6.49 | 3,330,121.00 | -0.5366 | 3.59 | -0.7644 | 5.21 | 16.03 | 14.15 | -2.28 | 9.89 | 0.7792 | -- | 0.2834 | 15.93 | -25.97 | -10.97 | -80.95 | -21.26 | 7.04 | -- |
| Dizal Jiangsu Pharmaceutical Co Ltd | 172.61m | -1.09bn | 16.25bn | 581.00 | -- | 23.33 | -- | 94.16 | -2.67 | -2.67 | 0.422 | 1.68 | 0.1008 | 0.3215 | 6.78 | 297,086.40 | -63.79 | -46.02 | -82.62 | -52.99 | 96.41 | 57.53 | -632.90 | -2,081.54 | 1.74 | -- | 0.4557 | -- | -- | 18.29 | -50.50 | -- | 21.35 | -- |
| Jiang Zhong Pharmaceutical Co Ltd | 4.30bn | 734.24m | 16.41bn | 4.01k | 22.37 | 3.98 | -- | 3.82 | 1.17 | 1.17 | 6.83 | 6.55 | 0.6698 | 4.34 | 13.62 | 1,071,799.00 | 12.35 | 10.82 | 18.82 | 15.08 | 64.01 | 65.02 | 18.44 | 18.17 | 1.47 | -- | 0.0061 | 82.88 | 13.00 | 20.12 | 18.40 | 8.54 | 11.47 | 40.99 |
| Anhui Huaheng Biotechnology Co Ltd | 2.04bn | 454.44m | 16.60bn | 1.69k | 36.59 | 8.67 | -- | 8.14 | 2.88 | 2.88 | 12.92 | 12.15 | 0.6196 | 5.59 | 8.04 | 1,205,674.00 | 13.71 | 16.74 | 21.59 | 22.41 | 38.49 | 39.21 | 22.13 | 22.34 | 0.4552 | 155.98 | 0.4552 | 25.20 | 36.63 | 35.72 | 40.32 | 42.84 | 82.09 | -- |
Data as of May 23 2024. Currency figures normalised to Shanghai Shyndec Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
6.12%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| E Fund Management Co., Ltd.as of 31 Dec 2023 | 24.54m | 1.83% |
| China Merchants Fund Management Co., Ltd.as of 30 Sep 2023 | 13.59m | 1.01% |
| Caitong Securities Asset Management Co., Ltd.as of 31 Dec 2023 | 10.00m | 0.75% |
| Monetary Authority of Macao (Investment Management)as of 30 Sep 2023 | 9.27m | 0.69% |
| JPMorgan Asset Management (China) Co Ltd.as of 31 Dec 2023 | 8.09m | 0.60% |
| CCB Principal Asset Management Co., Ltd.as of 31 Dec 2023 | 4.81m | 0.36% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 4.15m | 0.31% |
| The Vanguard Group, Inc.as of 30 Apr 2024 | 3.20m | 0.24% |
| HSBC Jintrust Fund Management Co. Ltd.as of 31 Dec 2023 | 2.27m | 0.17% |
| Wanjia Asset Management Co., Ltd.as of 31 Dec 2023 | 2.15m | 0.16% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
